Lenskart is gearing up for an IPO that could value the company at twice its previous funding round. This and more in today’s ...

The private equity market will likely drive IPO volumes higher than 2024 ... this year if conditions remain favorable. However, firms like Databricks, which just reached a $62 billion valuation ...

StubHub's IPO valuation is estimated at $16.5 billion, significantly higher than the $4.1 billion Viagogo paid eBay for the company back in 2020. "It looks like StubHub decided to postpone efforts ...

explaining that an IPO should be something biotechs always consider as a way of maintaining optionality. “I'm of the mindset that you should always be preparing for being public, just like you ...

Company cuts upper valuation guidance to $65 bln from $110 bln Investors balked at long-term sales guidance in IPO prospectus IPO ... prior to the revision who, like all the sources who spoke ...

Now, a judge has determined that Alcon’s consent is not required for an Aurion IPO, writing that the investor’s “argument is illogical in light of the parties’ contractual scheme ...

Jan 24 (Reuters) - The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White House, declining interest rates and a renewed risk-on ...

China-based biotech Ascentage Pharma has raised $126m in a US initial public offering (IPO), marking the first biotech IPO of 2025. The company sold 7,325,000 American Depositary shares at $17.25 ...

Thursday’s IPO included the offering of 70 million shares of Class A common stock at an initial price of $25 per share. With a total initial market cap of $65 billion, Venture Global (VG ...

Chinese biotech Ascentage Pharma has taken the first US biotech initial public offering (IPO) of 2025 over the finish line, raising $126 million for its pipeline of small-molecule cancer drugs.